img

Global Melatonin Receptor Agonists Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Melatonin Receptor Agonists Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Melatonin receptor agonists, also known as melatonin agonists or melatonergic drugs, are a class of medications that bind and activate melatonin receptors in the brain. These receptors play a crucial role in regulating the sleep-wake cycle and circadian rhythms.
Melatonin Receptor Agonists report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Melatonin Receptor Agonists market is projected to reach US$ 451.7 million in 2034, increasing from US$ 232 million in 2022, with the CAGR of 10.0% during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
The market for melatonin receptor agonists has witnessed growth in recent years due to the increasing recognition of the importance of sleep health and the rising prevalence of sleep disorders worldwide. Factors contributing to the market growth include lifestyle changes, stress-related sleep disturbances, shift work, and the growing elderly population, as sleep disorders tend to be more common in older adults.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Melatonin Receptor Agonists market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Takeda Pharmaceutical
Vanda Pharmaceuticals
Pfizer
Natrol
Pharmavite
Nature's Bounty
Jameison
Rexall Sundown
GNC
Xiu Zheng
Church & Dwight
BY-HEALTH
Solgar
Biotics Research
Now Food
Segment by Type
Ramelteon
Tasimelteon
Agomelatine
Other

Segment by Application


Hospital
Clinic
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Melatonin Receptor Agonists market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Melatonin Receptor Agonists, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Melatonin Receptor Agonists industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Melatonin Receptor Agonists in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Melatonin Receptor Agonists introduction, etc. Melatonin Receptor Agonists Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Melatonin Receptor Agonists market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Melatonin Receptor Agonists Market Overview
1.1 Melatonin Receptor Agonists Product Overview
1.2 Melatonin Receptor Agonists Market Segment by Type
1.2.1 Ramelteon
1.2.2 Tasimelteon
1.2.3 Agomelatine
1.2.4 Other
1.3 Global Melatonin Receptor Agonists Market Size by Type
1.3.1 Global Melatonin Receptor Agonists Market Size Overview by Type (2024-2034)
1.3.2 Global Melatonin Receptor Agonists Historic Market Size Review by Type (2024-2024)
1.3.3 Global Melatonin Receptor Agonists Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Melatonin Receptor Agonists Sales Breakdown by Type (2024-2024)
1.4.2 Europe Melatonin Receptor Agonists Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Melatonin Receptor Agonists Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Melatonin Receptor Agonists Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Melatonin Receptor Agonists Sales Breakdown by Type (2024-2024)
2 Global Melatonin Receptor Agonists Market Competition by Company
2.1 Global Top Players by Melatonin Receptor Agonists Sales (2024-2024)
2.2 Global Top Players by Melatonin Receptor Agonists Revenue (2024-2024)
2.3 Global Top Players by Melatonin Receptor Agonists Price (2024-2024)
2.4 Global Top Manufacturers Melatonin Receptor Agonists Manufacturing Base Distribution, Sales Area, Product Type
2.5 Melatonin Receptor Agonists Market Competitive Situation and Trends
2.5.1 Melatonin Receptor Agonists Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Melatonin Receptor Agonists Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Melatonin Receptor Agonists as of 2022)
2.7 Date of Key Manufacturers Enter into Melatonin Receptor Agonists Market
2.8 Key Manufacturers Melatonin Receptor Agonists Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Melatonin Receptor Agonists Status and Outlook by Region
3.1 Global Melatonin Receptor Agonists Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Melatonin Receptor Agonists Historic Market Size by Region
3.2.1 Global Melatonin Receptor Agonists Sales in Volume by Region (2024-2024)
3.2.2 Global Melatonin Receptor Agonists Sales in Value by Region (2024-2024)
3.2.3 Global Melatonin Receptor Agonists Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Melatonin Receptor Agonists Forecasted Market Size by Region
3.3.1 Global Melatonin Receptor Agonists Sales in Volume by Region (2024-2034)
3.3.2 Global Melatonin Receptor Agonists Sales in Value by Region (2024-2034)
3.3.3 Global Melatonin Receptor Agonists Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Melatonin Receptor Agonists by Application
4.1 Melatonin Receptor Agonists Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Melatonin Receptor Agonists Market Size by Application
4.2.1 Global Melatonin Receptor Agonists Market Size Overview by Application (2024-2034)
4.2.2 Global Melatonin Receptor Agonists Historic Market Size Review by Application (2024-2024)
4.2.3 Global Melatonin Receptor Agonists Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Melatonin Receptor Agonists Sales Breakdown by Application (2024-2024)
4.3.2 Europe Melatonin Receptor Agonists Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Melatonin Receptor Agonists Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Melatonin Receptor Agonists Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Melatonin Receptor Agonists Sales Breakdown by Application (2024-2024)
5 North America Melatonin Receptor Agonists by Country
5.1 North America Melatonin Receptor Agonists Historic Market Size by Country
5.1.1 North America Melatonin Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Melatonin Receptor Agonists Sales in Volume by Country (2024-2024)
5.1.3 North America Melatonin Receptor Agonists Sales in Value by Country (2024-2024)
5.2 North America Melatonin Receptor Agonists Forecasted Market Size by Country
5.2.1 North America Melatonin Receptor Agonists Sales in Volume by Country (2024-2034)
5.2.2 North America Melatonin Receptor Agonists Sales in Value by Country (2024-2034)
6 Europe Melatonin Receptor Agonists by Country
6.1 Europe Melatonin Receptor Agonists Historic Market Size by Country
6.1.1 Europe Melatonin Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Melatonin Receptor Agonists Sales in Volume by Country (2024-2024)
6.1.3 Europe Melatonin Receptor Agonists Sales in Value by Country (2024-2024)
6.2 Europe Melatonin Receptor Agonists Forecasted Market Size by Country
6.2.1 Europe Melatonin Receptor Agonists Sales in Volume by Country (2024-2034)
6.2.2 Europe Melatonin Receptor Agonists Sales in Value by Country (2024-2034)
7 Asia-Pacific Melatonin Receptor Agonists by Region
7.1 Asia-Pacific Melatonin Receptor Agonists Historic Market Size by Region
7.1.1 Asia-Pacific Melatonin Receptor Agonists Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Melatonin Receptor Agonists Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Melatonin Receptor Agonists Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Melatonin Receptor Agonists Forecasted Market Size by Region
7.2.1 Asia-Pacific Melatonin Receptor Agonists Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Melatonin Receptor Agonists Sales in Value by Region (2024-2034)
8 Latin America Melatonin Receptor Agonists by Country
8.1 Latin America Melatonin Receptor Agonists Historic Market Size by Country
8.1.1 Latin America Melatonin Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Melatonin Receptor Agonists Sales in Volume by Country (2024-2024)
8.1.3 Latin America Melatonin Receptor Agonists Sales in Value by Country (2024-2024)
8.2 Latin America Melatonin Receptor Agonists Forecasted Market Size by Country
8.2.1 Latin America Melatonin Receptor Agonists Sales in Volume by Country (2024-2034)
8.2.2 Latin America Melatonin Receptor Agonists Sales in Value by Country (2024-2034)
9 Middle East and Africa Melatonin Receptor Agonists by Country
9.1 Middle East and Africa Melatonin Receptor Agonists Historic Market Size by Country
9.1.1 Middle East and Africa Melatonin Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Melatonin Receptor Agonists Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Melatonin Receptor Agonists Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Melatonin Receptor Agonists Forecasted Market Size by Country
9.2.1 Middle East and Africa Melatonin Receptor Agonists Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Melatonin Receptor Agonists Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Takeda Pharmaceutical
10.1.1 Takeda Pharmaceutical Company Information
10.1.2 Takeda Pharmaceutical Introduction and Business Overview
10.1.3 Takeda Pharmaceutical Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Takeda Pharmaceutical Melatonin Receptor Agonists Products Offered
10.1.5 Takeda Pharmaceutical Recent Development
10.2 Vanda Pharmaceuticals
10.2.1 Vanda Pharmaceuticals Company Information
10.2.2 Vanda Pharmaceuticals Introduction and Business Overview
10.2.3 Vanda Pharmaceuticals Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Vanda Pharmaceuticals Melatonin Receptor Agonists Products Offered
10.2.5 Vanda Pharmaceuticals Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Pfizer Melatonin Receptor Agonists Products Offered
10.3.5 Pfizer Recent Development
10.4 Natrol
10.4.1 Natrol Company Information
10.4.2 Natrol Introduction and Business Overview
10.4.3 Natrol Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Natrol Melatonin Receptor Agonists Products Offered
10.4.5 Natrol Recent Development
10.5 Pharmavite
10.5.1 Pharmavite Company Information
10.5.2 Pharmavite Introduction and Business Overview
10.5.3 Pharmavite Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Pharmavite Melatonin Receptor Agonists Products Offered
10.5.5 Pharmavite Recent Development
10.6 Nature's Bounty
10.6.1 Nature's Bounty Company Information
10.6.2 Nature's Bounty Introduction and Business Overview
10.6.3 Nature's Bounty Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Nature's Bounty Melatonin Receptor Agonists Products Offered
10.6.5 Nature's Bounty Recent Development
10.7 Jameison
10.7.1 Jameison Company Information
10.7.2 Jameison Introduction and Business Overview
10.7.3 Jameison Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Jameison Melatonin Receptor Agonists Products Offered
10.7.5 Jameison Recent Development
10.8 Rexall Sundown
10.8.1 Rexall Sundown Company Information
10.8.2 Rexall Sundown Introduction and Business Overview
10.8.3 Rexall Sundown Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Rexall Sundown Melatonin Receptor Agonists Products Offered
10.8.5 Rexall Sundown Recent Development
10.9 GNC
10.9.1 GNC Company Information
10.9.2 GNC Introduction and Business Overview
10.9.3 GNC Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2024-2024)
10.9.4 GNC Melatonin Receptor Agonists Products Offered
10.9.5 GNC Recent Development
10.10 Xiu Zheng
10.10.1 Xiu Zheng Company Information
10.10.2 Xiu Zheng Introduction and Business Overview
10.10.3 Xiu Zheng Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Xiu Zheng Melatonin Receptor Agonists Products Offered
10.10.5 Xiu Zheng Recent Development
10.11 Church & Dwight
10.11.1 Church & Dwight Company Information
10.11.2 Church & Dwight Introduction and Business Overview
10.11.3 Church & Dwight Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Church & Dwight Melatonin Receptor Agonists Products Offered
10.11.5 Church & Dwight Recent Development
10.12 BY-HEALTH
10.12.1 BY-HEALTH Company Information
10.12.2 BY-HEALTH Introduction and Business Overview
10.12.3 BY-HEALTH Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2024-2024)
10.12.4 BY-HEALTH Melatonin Receptor Agonists Products Offered
10.12.5 BY-HEALTH Recent Development
10.13 Solgar
10.13.1 Solgar Company Information
10.13.2 Solgar Introduction and Business Overview
10.13.3 Solgar Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Solgar Melatonin Receptor Agonists Products Offered
10.13.5 Solgar Recent Development
10.14 Biotics Research
10.14.1 Biotics Research Company Information
10.14.2 Biotics Research Introduction and Business Overview
10.14.3 Biotics Research Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Biotics Research Melatonin Receptor Agonists Products Offered
10.14.5 Biotics Research Recent Development
10.15 Now Food
10.15.1 Now Food Company Information
10.15.2 Now Food Introduction and Business Overview
10.15.3 Now Food Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Now Food Melatonin Receptor Agonists Products Offered
10.15.5 Now Food Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Melatonin Receptor Agonists Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Melatonin Receptor Agonists Industrial Chain Analysis
11.4 Melatonin Receptor Agonists Market Dynamics
11.4.1 Melatonin Receptor Agonists Industry Trends
11.4.2 Melatonin Receptor Agonists Market Drivers
11.4.3 Melatonin Receptor Agonists Market Challenges
11.4.4 Melatonin Receptor Agonists Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Melatonin Receptor Agonists Distributors
12.3 Melatonin Receptor Agonists Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Ramelteon
Table 2. Major Company of Tasimelteon
Table 3. Major Company of Agomelatine
Table 4. Major Company of Other
Table 5. Global Melatonin Receptor Agonists Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Melatonin Receptor Agonists Sales by Type (2024-2024) & (K Units)
Table 7. Global Melatonin Receptor Agonists Sales Market Share in Volume by Type (2024-2024)
Table 8. Global Melatonin Receptor Agonists Sales by Type (2024-2024) & (US& Million)
Table 9. Global Melatonin Receptor Agonists Market Share in Value by Type (2024-2024)
Table 10. Global Melatonin Receptor Agonists Price by Type (2024-2024) & (US$/Unit)
Table 11. Global Melatonin Receptor Agonists Sales by Type (2024-2034) & (K Units)
Table 12. Global Melatonin Receptor Agonists Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Melatonin Receptor Agonists Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Melatonin Receptor Agonists Sales Market Share in Value by Type (2024-2034)
Table 15. Global Melatonin Receptor Agonists Price by Type (2024-2034) & (US$/Unit)
Table 16. North America Melatonin Receptor Agonists Sales by Type (2024-2024) & (K Units)
Table 17. North America Melatonin Receptor Agonists Sales by Type (2024-2024) & (US$ Million)
Table 18. Europe Melatonin Receptor Agonists Sales (K Units) by Type (2024-2024)
Table 19. Europe Melatonin Receptor Agonists Sales by Type (2024-2024) & (US$ Million)
Table 20. Asia-Pacific Melatonin Receptor Agonists Sales (K Units) by Type (2024-2024)
Table 21. Asia-Pacific Melatonin Receptor Agonists Sales by Type (2024-2024) & (US$ Million)
Table 22. Latin America Melatonin Receptor Agonists Sales (K Units) by Type (2024-2024)
Table 23. Latin America Melatonin Receptor Agonists Sales by Type (2024-2024) & (US$ Million)
Table 24. Middle East and Africa Melatonin Receptor Agonists Sales (K Units) by Type (2024-2024)
Table 25. Middle East and Africa Melatonin Receptor Agonists Sales by Type (2024-2024) & (US$ Million)
Table 26. Global Melatonin Receptor Agonists Sales by Company (2024-2024) & (K Units)
Table 27. Global Melatonin Receptor Agonists Sales Share by Company (2024-2024)
Table 28. Global Melatonin Receptor Agonists Revenue by Company (2024-2024) & (US$ Million)
Table 29. Global Melatonin Receptor Agonists Revenue Share by Company (2024-2024)
Table 30. Global Market Melatonin Receptor Agonists Price by Company (2024-2024) & (US$/Unit)
Table 31. Global Melatonin Receptor Agonists Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Melatonin Receptor Agonists Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Melatonin Receptor Agonists as of 2022)
Table 34. Date of Key Manufacturers Enter into Melatonin Receptor Agonists Market
Table 35. Key Manufacturers Melatonin Receptor Agonists Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Melatonin Receptor Agonists Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Global Melatonin Receptor Agonists Sales by Region (2024-2024) & (K Units)
Table 39. Global Melatonin Receptor Agonists Sales Market Share in Volume by Region (2024-2024)
Table 40. Global Melatonin Receptor Agonists Sales by Region (2024-2024) & (US$ Million)
Table 41. Global Melatonin Receptor Agonists Sales Market Share in Value by Region (2024-2024)
Table 42. Global Melatonin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 43. Global Melatonin Receptor Agonists Sales by Region (2024-2034) & (K Units)
Table 44. Global Melatonin Receptor Agonists Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Melatonin Receptor Agonists Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Melatonin Receptor Agonists Sales Market Share in Value by Region (2024-2034)
Table 47. Global Melatonin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 48. Global Melatonin Receptor Agonists Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 49. Global Melatonin Receptor Agonists Sales by Application (2024-2024) & (K Units)
Table 50. Global Melatonin Receptor Agonists Sales Market Share in Volume by Application (2024-2024)
Table 51. Global Melatonin Receptor Agonists Sales by Application (2024-2024) & (US$ Million)
Table 52. Global Melatonin Receptor Agonists Sales Market Share in Value by Application (2024-2024)
Table 53. Global Melatonin Receptor Agonists Price by Application (2024-2024) & (US$/Unit)
Table 54. Global Melatonin Receptor Agonists Sales by Application (2024-2034) & (K Units)
Table 55. Global Melatonin Receptor Agonists Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Melatonin Receptor Agonists Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Melatonin Receptor Agonists Sales Market Share in Value by Application (2024-2034)
Table 58. Global Melatonin Receptor Agonists Price by Application (2024-2034) & (US$/Unit)
Table 59. North America Melatonin Receptor Agonists Sales by Application (2024-2024) (K Units)
Table 60. North America Melatonin Receptor Agonists Sales by Application (2024-2024) & (US$ Million)
Table 61. Europe Melatonin Receptor Agonists Sales by Application (2024-2024) (K Units)
Table 62. Europe Melatonin Receptor Agonists Sales by Application (2024-2024) & (US$ Million)
Table 63. Asia-Pacific Melatonin Receptor Agonists Sales by Application (2024-2024) (K Units)
Table 64. Asia-Pacific Melatonin Receptor Agonists Sales by Application (2024-2024) & (US$ Million)
Table 65. Latin America Melatonin Receptor Agonists Sales by Application (2024-2024) (K Units)
Table 66. Latin America Melatonin Receptor Agonists Sales by Application (2024-2024) & (US$ Million)
Table 67. Middle East and Africa Melatonin Receptor Agonists Sales by Application (2024-2024) (K Units)
Table 68. Middle East and Africa Melatonin Receptor Agonists Sales by Application (2024-2024) & (US$ Million)
Table 69. North America Melatonin Receptor Agonists Sales by Country (2024-2024) & (K Units)
Table 70. North America Melatonin Receptor Agonists Sales Market Share in Volume by Country (2024-2024)
Table 71. North America Melatonin Receptor Agonists Sales by Country (2024-2024) & (US$ Million)
Table 72. North America Melatonin Receptor Agonists Sales Market Share in Value by Country (2024-2024)
Table 73. North America Melatonin Receptor Agonists Sales by Country (2024-2034) & (K Units)
Table 74. North America Melatonin Receptor Agonists Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Melatonin Receptor Agonists Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Melatonin Receptor Agonists Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Melatonin Receptor Agonists Sales by Country (2024-2024) & (K Units)
Table 78. Europe Melatonin Receptor Agonists Sales Market Share in Volume by Country (2024-2024)
Table 79. Europe Melatonin Receptor Agonists Sales by Country (2024-2024) & (US$ Million)
Table 80. Europe Melatonin Receptor Agonists Sales Market Share in Value by Country (2024-2024)
Table 81. Europe Melatonin Receptor Agonists Sales by Country (2024-2034) & (K Units)
Table 82. Europe Melatonin Receptor Agonists Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Melatonin Receptor Agonists Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Melatonin Receptor Agonists Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Melatonin Receptor Agonists Sales by Region (2024-2024) & (K Units)
Table 86. Asia-Pacific Melatonin Receptor Agonists Sales Market Share in Volume by Region (2024-2024)
Table 87. Asia-Pacific Melatonin Receptor Agonists Sales by Region (2024-2024) & (US$ Million)
Table 88. Asia-Pacific Melatonin Receptor Agonists Sales Market Share in Value by Region (2024-2024)
Table 89. Asia-Pacific Melatonin Receptor Agonists Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Melatonin Receptor Agonists Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Melatonin Receptor Agonists Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Melatonin Receptor Agonists Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Melatonin Receptor Agonists Sales by Country (2024-2024) & (K Units)
Table 94. Latin America Melatonin Receptor Agonists Sales Market Share in Volume by Country (2024-2024)
Table 95. Latin America Melatonin Receptor Agonists Sales by Country (2024-2024) & (US$ Million)
Table 96. Latin America Melatonin Receptor Agonists Sales Market Share in Value by Country (2024-2024)
Table 97. Latin America Melatonin Receptor Agonists Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Melatonin Receptor Agonists Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Melatonin Receptor Agonists Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Melatonin Receptor Agonists Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Melatonin Receptor Agonists Sales by Country (2024-2024) & (K Units)
Table 102. Middle East and Africa Melatonin Receptor Agonists Sales Market Share in Volume by Country (2024-2024)
Table 103. Middle East and Africa Melatonin Receptor Agonists Sales by Country (2024-2024) & (US$ Million)
Table 104. Middle East and Africa Melatonin Receptor Agonists Sales Market Share in Value by Country (2024-2024)
Table 105. Middle East and Africa Melatonin Receptor Agonists Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Melatonin Receptor Agonists Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Melatonin Receptor Agonists Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Melatonin Receptor Agonists Sales Market Share in Value by Country (2024-2034)
Table 109. Takeda Pharmaceutical Company Information
Table 110. Takeda Pharmaceutical Introduction and Business Overview
Table 111. Takeda Pharmaceutical Melatonin Receptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 112. Takeda Pharmaceutical Melatonin Receptor Agonists Product
Table 113. Takeda Pharmaceutical Recent Development
Table 114. Vanda Pharmaceuticals Company Information
Table 115. Vanda Pharmaceuticals Introduction and Business Overview
Table 116. Vanda Pharmaceuticals Melatonin Receptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 117. Vanda Pharmaceuticals Melatonin Receptor Agonists Product
Table 118. Vanda Pharmaceuticals Recent Development
Table 119. Pfizer Company Information
Table 120. Pfizer Introduction and Business Overview
Table 121. Pfizer Melatonin Receptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 122. Pfizer Melatonin Receptor Agonists Product
Table 123. Pfizer Recent Development
Table 124. Natrol Company Information
Table 125. Natrol Introduction and Business Overview
Table 126. Natrol Melatonin Receptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 127. Natrol Melatonin Receptor Agonists Product
Table 128. Natrol Recent Development
Table 129. Pharmavite Company Information
Table 130. Pharmavite Introduction and Business Overview
Table 131. Pharmavite Melatonin Receptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 132. Pharmavite Melatonin Receptor Agonists Product
Table 133. Pharmavite Recent Development
Table 134. Nature's Bounty Company Information
Table 135. Nature's Bounty Introduction and Business Overview
Table 136. Nature's Bounty Melatonin Receptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 137. Nature's Bounty Melatonin Receptor Agonists Product
Table 138. Nature's Bounty Recent Development
Table 139. Jameison Company Information
Table 140. Jameison Introduction and Business Overview
Table 141. Jameison Melatonin Receptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 142. Jameison Melatonin Receptor Agonists Product
Table 143. Jameison Recent Development
Table 144. Rexall Sundown Company Information
Table 145. Rexall Sundown Introduction and Business Overview
Table 146. Rexall Sundown Melatonin Receptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 147. Rexall Sundown Melatonin Receptor Agonists Product
Table 148. Rexall Sundown Recent Development
Table 149. GNC Company Information
Table 150. GNC Introduction and Business Overview
Table 151. GNC Melatonin Receptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 152. GNC Melatonin Receptor Agonists Product
Table 153. GNC Recent Development
Table 154. Xiu Zheng Company Information
Table 155. Xiu Zheng Introduction and Business Overview
Table 156. Xiu Zheng Melatonin Receptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 157. Xiu Zheng Melatonin Receptor Agonists Product
Table 158. Xiu Zheng Recent Development
Table 159. Church & Dwight Company Information
Table 160. Church & Dwight Introduction and Business Overview
Table 161. Church & Dwight Melatonin Receptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 162. Church & Dwight Melatonin Receptor Agonists Product
Table 163. Church & Dwight Recent Development
Table 164. BY-HEALTH Company Information
Table 165. BY-HEALTH Introduction and Business Overview
Table 166. BY-HEALTH Melatonin Receptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 167. BY-HEALTH Melatonin Receptor Agonists Product
Table 168. BY-HEALTH Recent Development
Table 169. Solgar Company Information
Table 170. Solgar Introduction and Business Overview
Table 171. Solgar Melatonin Receptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 172. Solgar Melatonin Receptor Agonists Product
Table 173. Solgar Recent Development
Table 174. Biotics Research Company Information
Table 175. Biotics Research Introduction and Business Overview
Table 176. Biotics Research Melatonin Receptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 177. Biotics Research Melatonin Receptor Agonists Product
Table 178. Biotics Research Recent Development
Table 179. Now Food Company Information
Table 180. Now Food Introduction and Business Overview
Table 181. Now Food Melatonin Receptor Agonists Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 182. Now Food Melatonin Receptor Agonists Product
Table 183. Now Food Recent Development
Table 184. Key Raw Materials Lists
Table 185. Raw Materials Key Suppliers Lists
Table 186. Melatonin Receptor Agonists Market Trends
Table 187. Melatonin Receptor Agonists Market Drivers
Table 188. Melatonin Receptor Agonists Market Challenges
Table 189. Melatonin Receptor Agonists Market Restraints
Table 190. Melatonin Receptor Agonists Distributors List
Table 191. Melatonin Receptor Agonists Downstream Customers
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Melatonin Receptor Agonists Product Picture
Figure 2. Global Melatonin Receptor Agonists Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Melatonin Receptor Agonists Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Melatonin Receptor Agonists Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Ramelteon
Figure 6. Global Ramelteon Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Tasimelteon
Figure 8. Global Tasimelteon Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Agomelatine
Figure 10. Global Agomelatine Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Other
Figure 12. Global Other Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Global Melatonin Receptor Agonists Sales by Type (2024-2034) & (US$ Million)
Figure 14. Global Melatonin Receptor Agonists Sales Market Share by Type in 2022 & 2034
Figure 15. North America Melatonin Receptor Agonists Sales Market Share in Volume by Type in 2022
Figure 16. North America Melatonin Receptor Agonists Sales Market Share in Value by Type in 2022
Figure 17. Europe Melatonin Receptor Agonists Sales Market Share in Volume by Type in 2022
Figure 18. Europe Melatonin Receptor Agonists Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Melatonin Receptor Agonists Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Melatonin Receptor Agonists Sales Market Share in Value by Type in 2022
Figure 21. Latin America Melatonin Receptor Agonists Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Melatonin Receptor Agonists Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Melatonin Receptor Agonists Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Melatonin Receptor Agonists Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Melatonin Receptor Agonists Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Melatonin Receptor Agonists Revenue in 2022
Figure 27. Melatonin Receptor Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Clinic
Figure 31. Global Clinic Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Other
Figure 33. Global Other Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Global Melatonin Receptor Agonists Sales by Application (2024-2034) & (US$ Million)
Figure 35. Global Melatonin Receptor Agonists Sales Market Share by Application in 2022 & 2034
Figure 36. North America Melatonin Receptor Agonists Sales Market Share in Volume by Application in 2022
Figure 37. North America Melatonin Receptor Agonists Sales Market Share in Value by Application in 2022
Figure 38. Europe Melatonin Receptor Agonists Sales Market Share in Volume by Application in 2022
Figure 39. Europe Melatonin Receptor Agonists Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Melatonin Receptor Agonists Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Melatonin Receptor Agonists Sales Market Share in Value by Application in 2022
Figure 42. Latin America Melatonin Receptor Agonists Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Melatonin Receptor Agonists Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Melatonin Receptor Agonists Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Melatonin Receptor Agonists Manufacturing Cost Structure
Figure 47. Melatonin Receptor Agonists Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed